Table 1 Baseline Characteristics of the Cohort
Variable | Baseline |
|---|---|
Cardiovascular Disease Risk Factors | |
Hypertension | 6 (60%) |
Diabetes Mellitus | 4 (40%) |
Hyperlipidemia | 6 (60%) |
Tobacco smoking history | 8 (80%) |
Obesity | 5 (50%) |
Sedentary Lifestyle | 4 (40%) |
Cardiovascular Medications | |
Beta-blockers | 5 (50%) |
ACE-I/ARB | 5 (50%) |
Statins | 5 (50%) |
Comorbidities | |
COPD | 5 (50%) |
COPD stage (GOLD criteria) | Moderate: 4 (40%) Severe: 1 (10%) |
Prior other cancers | 4 (40%) |
Chronic kidney disease | 2 (20%) |
Oncologic Staging and Treatment | |
Lung Cancer Stage | IIB: 2 (20%) IIIA: 2 (20%) IIIB: 5 (50%) IV: 1 (10%) |
Lung Cancer tissue type | Adenocarcinoma: 4 (40%) Squamous cell cancer: 3 (30%) Small cell cancer: 2 (20%) Poorly differentiated cancer: 1 (10%) |
Tumor Location | Â |
 Left Upper Lobe  Right Upper Lobe | 6 (60%) 4 (40%) |
Radiotherapy Parameters | Â |
 MLRD, Gy  MCRD, Gy  Heart Max Dose, Gy  Heart V5 Gy, %  Heart V10 Gy, %  Heart V20 Gy, %  Heart V30 Gy, %  Heart V40 Gy, %  Heart V50 Gy, % | 11.0 [8.8–13.7] 8.1 [4.8–12.4] 65.3 [64.2–67.2] 39.0 [18.3–54.5] 26.0 [11.8–35.0] 11.5 [6.5–20.8] 5.0 [3.0-13.5] 2.5 [1.5–8.8] 1.5 [0.75-4.0] |